Evaluation of pancreatic cancer cell lines as a source of cancer stem cells (CSC) and their utilisation for assessing anti-CSC activities of KRAS binders
Background: High incidence of recurrence has been recorded at 80% of pancreatic ductal adenocarcinoma (PDAC) cases, despite tumour resection and an adjuvant chemotherapy with gemcitabine are prescribed. Pancreatic cancer stem cells (CSCs) are believed to have initiated recurrent PDAC. Growing ev...
| 第一著者: | |
|---|---|
| フォーマット: | 学位論文 |
| 言語: | 英語 |
| 出版事項: |
2020
|
| 主題: | |
| オンライン･アクセス: | http://psasir.upm.edu.my/id/eprint/116093/1/116093.pdf |